In the ever-evolving landscape of health technology, it's partnerships that often drive the most transformative changes. Medical Intelligence Group (MIG), founded in 2020, serves as a prime example. This ambitious health-tech company emerged with a clear vision: to revolutionize healthcare using AI technology, delivering patient-centric solutions that don't break the bank. But every visionary company needs allies, and for MIG, those came in the form of Innovate UK EDGE and the Enterprise Europe Network.
Starting from its foundational goals to tackle healthcare inequalities with reliable and cost-effective solutions, MIG quickly gained momentum. Within the first quarter of its inception, support from Innovate UK, Innovate UK EDGE, and the Enterprise Europe Network propelled MIG's mission of championing preventative healthcare solutions. Among its pioneering ventures is the integration of 3D scanning technology with AI, aimed at mitigating the distressing prevalence of diabetic foot ulcers. A major concern in the UK, these ulcers can escalate into the need for foot amputations if not addressed promptly and efficiently.
While the technical side of things is one challenge, navigating the labyrinthine corridors of the NHS presented another. Getting the technology into the hands of those who need it most requires understanding, connection, and the right strategy. Every layer of the NHS, from the administrative to the clinical, needed to be approached, understood, and convinced of MIG’s value. It's here that the support from Innovate UK EDGE and the Enterprise Europe Network proved invaluable.
These partnerships helped MIG not only pinpoint the correct NHS channels but also tailor their communication to resonate with diverse stakeholders, from patients to medical staff. Through their vast networks, Innovate UK EDGE and the Enterprise Europe Network connected MIG with influential clinical collaborators, culminating in MIG’s groundbreaking pilot trial with the NHS.
The collaboration didn't stop there. From strategic planning to business development, Innovate UK EDGE and the Enterprise Europe Network have continuously backed MIG. Workshops focusing on Intellectual Property ensured MIG's innovative technology remained safeguarded. Additionally, strategy sessions illuminated pathways to not just national, but global outreach.
With the added boost of an InnovateUK grant, MIG transformed its initial concepts into tangible, clinically testable technologies. This evolution also witnessed the expansion of MIG’s skilled team, now boasting research engineers, software engineers, and UI/UX designers.
In the fight against diabetic foot ulcers, MIG, backed by its robust partners, is proving that with the right support, technology, and drive, monumental challenges in healthcare can be addressed, paving the way for a healthier future.